Fisetin suppresses colorectal cancer growth through AKAP12 in the patient-derived organoid xenograft model

ABSTRACT: To investigate the genetic changes induced by fisetin treatment, we established a patient-derived organoid xenograft model (PDOX) of the control group and the group treated with fisetin 200mpk. We then performed gene expression profiling analysis using data from RNA-seq from both groups.

ORGANISM(S): Homo sapiens

PROVIDER: GSE213963 | GEO | 2023/10/10

REPOSITORIES: GEO